Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply
- PMID: 33406339
- DOI: 10.1056/NEJMc2032399
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply
Comment on
-
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.N Engl J Med. 2021 Jan 7;384(1):84. doi: 10.1056/NEJMc2032399. N Engl J Med. 2021. PMID: 33406338 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources